Suchergebnisse - "Siegel, Corey A"

PubPharm (28)

1

Comparative Safety and Effectiveness of Vedolizumab to Tumor Necrosis Factor Antagonist Therapy for Ulcerative Colitis

enthalten in: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association | 2022

von Lukin, D. | Faleck, D. | Xu, R. | +33

2

Development and Validation of Clinical Scoring Tool to Predict Outcomes of Treatment With Vedolizumab in Patients With Ulcerative Colitis

enthalten in: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association | 2020

von Dulai, P. | Singh, S. | Vande Casteele, N. | +37

3

A clinical decision support tool may help to optimise vedolizumab therapy in Crohn's disease

enthalten in: Alimentary pharmacology & therapeutics | 2020

von Dulai, P. | Amiot, A. | Peyrin-Biroulet, L. | +95

CommentIn: Aliment Pharmacol Ther. 2020 Apr;51(7):738-739. - PMID 32162371

4

Shorter Disease Duration Is Associated With Higher Rates of Response to Vedolizumab in Patients With Crohn's Disease But Not Ulcerative Colitis

enthalten in: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association | 2019

von Faleck, D. | Winters, A. | Chablaney, S. | +31

CommentIn: Clin Gastroenterol Hepatol. 2019 Jul;17(8):1646. - PMID 30664948

5

Changes in Vedolizumab Utilization Across US Academic Centers and Community Practice Are Associated With Improved Effectiveness and Disease Outcomes

enthalten in: Inflammatory bowel diseases | 2019

von Koliani-Pace, J. | Singh, S. | Luo, M. | +32

6

Appropriate Therapeutic Drug Monitoring of Biologic Agents for Patients With Inflammatory Bowel Diseases

enthalten in: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association | 2019

von Papamichael, K. | Cheifetz, A. | Melmed, G. | +13

CommentIn: Clin Gastroenterol Hepatol. 2019 Aug;17(9):1718-1723. - PMID 31255806

7

Retrospective Analysis of Safety of Vedolizumab in Patients With Inflammatory Bowel Diseases

enthalten in: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association | 2019

von Meserve, J. | Aniwan, S. | Koliani-Pace, J. | +30

8

ACG Clinical Guideline : Ulcerative Colitis in Adults

enthalten in: The American journal of gastroenterology | 2019

von Rubin, D. | Ananthakrishnan, A. | Siegel, C. | +2

9

Gene Expression Signature for Prediction of Golimumab Response in a Phase 2a Open-Label Trial of Patients With Ulcerative Colitis

enthalten in: Gastroenterology | 2018

von Telesco, S. | Brodmerkel, C. | Zhang, H. | +18

CommentIn: Gastroenterology. 2018 Oct;155(4):963-964. - PMID 30201343

10

Predictors and Management of Loss of Response to Vedolizumab in Inflammatory Bowel Disease

enthalten in: Inflammatory bowel diseases | 2018

von Shmidt, E. | Kochhar, G. | Hartke, J. | +29

CommentIn: Inflamm Bowel Dis. 2019 Apr 11;25(5):e59. - PMID 31222304